MELBOURNE, Australia and OXFORD, United Kingdom, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing ...

CHARLOTTESVILLE, Va. and SAN FRANCISCO, Jan. 8, 2025 /PRNewswire/ -- Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven ...

(Image Credits: Pixabay) Amid the growing burden of non-communicable diseases and ageing population, the pharmaceutical sector has thrived tremendously over the recent years. Industry leaders ...

The hefty tariffs President-elect Trump has pledged to levy on U.S. imports could impact the price and availability of pharmaceutical drugs. Trump has floated 25 percent tariffs on imports from ...

This scenario indicates that 2025 will be a promising year for the pharma sector. A report by Axis Securities last month outlined a positive outlook for the pharmaceutical sector over the next three ...

Tales of the Shire: A Lord of the Rings Game is slated for official release on March 25, 2025, allowing players to create a unique hobbit, customize a hobbit hole and garden, forage and fish for ...

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO) is pleased to announce the opening of the first clinical site for its lead asset, HG-CT-1, targeting relapsed ...

STOCKHOLM & RADNOR, Pa.--(BUSINESS WIRE)--$MRNS #MarinusPharma--Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc ...

Private Division and Wētā Workshop have confirmed a release date for Tales of the Shire: A The Lord of the Rings Game on Nintendo Switch. You will have the chance to experience the storybook return to ...

British car brand Jaguar unveiled a new logo and wordmark as part of the company's shift away from making petrol-powered cars towards electric only. The new branding centres around an uppercase J ...

Vertex Pharmaceuticals is trying to diversify its product portfolio. One of the programs it's working on aims to treat pain in a few contexts. There's reason to believe that it won't be effective ...

Prior to Galderma, Ms. Kalofonos held roles of increasing responsibility at Takeda Pharmaceuticals (formerly Shire), most recently serving as Vice President and Head of the Hereditary Angioedema ...